Is there any place for PD-1/CTLA-4 inhibitors combination in the first-line treatment of advanced NSCLC?—a trial-level meta-analysis in PD-L1 selected subgroups

Authors:
  • FPFrancesco Passiglia
    Francesco Passiglia
  • AGAntonio Galvano
    Antonio Galvano
  • VGValerio Gristina
    Valerio Gristina
  • NBNadia Barraco
    Nadia Barraco
  • MCMarta Castiglia
    Marta Castiglia
  • APAlessandro Perez
    Alessandro Perez
  • MMMaria La Mantia
    Maria La Mantia
  • VBViviana Bazan
    Viviana Bazan

Abstract
Is there any place for PD-1/CTLA-4 inhibitors combination in the first-line treatment of advanced NSCLC?—A trial-level meta-analysis in PD-L1 selected subgroups Francesco Passiglia, Antonio Galvano, Valerio Gristina, Nadia Barraco, Marta Castiglia, Alessandro Perez, Maria La Mantia, Antonio Russo, Viviana Bazan

This publication has 17 references indexed in Scilit: